[ET Net News Agency, 27 May 2022] HSBC Global Research lowered its target price for Ali
Health (00241) to HK$5.5 from HK$8.7 and maintained its "buy" rating.
The research house said taking into account the potential regulatory impact, it trims
FY23e-25e topline by 9-15%. (RC)